ERAS-4001

N/A

Report date: 2025/06/17 20:00:11
NME

Base Information

Drug NameERAS-4001
Drug Alias NameERAS-4001
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors
TargetsGTPase KRas
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesErasca Inc
China Registration ClassN/A

Develop Information

Active CompaniesErasca Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A